Professor Dedee Murrell
ICD 2021 Congress President – University of NSW, Sydney

Professor Dedee Murrell is President of ICD2021. She is the Chair of the Department of Dermatology at St George Hospital at the University of New South Wales (UNSW) in Sydney. She is the immediate past President of the Australasian Society of Dermatology Research (ASDR), the first elected international board member of the EADV and past Executive Vice President of the International Society of Dermatology.

Professor Murrell has over 350 research publications, has edited six textbooks of dermatology focused on blistering diseases and is founding Co-Editor of the International Journal of Women’s Dermatology. She serves on the editorial boards of the BJD, JEADV, IJD and JAMA Dermatology.

Her research interests include the treatment and pathogenesis of pemphigus, bullous pemphigoid, EBA and Epidermolysis Bullosa. Professor Murrell conducts clinical research in these conditions as well as for atopic dermatitis, psoriasis, genetic and autoimmune skin diseases, acne, rosacea and skin cancer. She has trained over 50 international fellows in dermatology.

Emma Guttman
Waldman Professor and System Chair – Mount Sinai

Prof Sonja Ständer

Prof Rod Sinclair

Professor Rodney Sinclair is a Professor of Dermatology at the University of Melbourne and Director of Epworth Dermatology. He is past-president of the Australasian Society for Dermatology Research, the Australasian Hair and Wool Research Society and the Skin and Cancer Foundation of Victoria.

Professor Sinclair is the co-author of the section on dermatology in the Oxford Textbook of Medicine and lead author of Therapeutic Guidelines – Dermatology. He has written 13 textbooks on dermatology and over 400 research publications to his name. His research is highly cited, and treatment of hair loss receives regular requests for media commentary.

His main research interests are the treatment of hair loss, skin cancer epidemiology, psoriasis, genetic diseases of the skin, autoimmune diseases of the skin, skin immunology and hair and skin stem cell biology. Professor Sinclair conducts clinical research in psoriasis, hair loss and skin cancer prevention and treatment and laboratory research into stem cell biology, regenerative medicine and gene discovery. He is considered a world leader in hair disease, nail disease, psoriasis and skin cancer diagnosis and treatment.

Professor Saxon D. Smith (AUS)

MBChB, MHL, PhD, GAICD, FAMA, IFAAD, FACD
Dermatologist

Professor Saxon D Smith is a Fellow of the Australasian College of Dermatologists.  He is the principal dermatologist at The Dermatology and Skin Cancer Centre in Gosford and St Leonards, NSW, Australia.  He is a past president of the Australian Medical Association in NSW.

Professor Smith has extensive clinical and research interests including atopic dermatitis, psoriasis, hidradenitis suppurativa, melanoma, non-melanoma skin cancer, and management of cutaneous adverse drug reactions in oncology and neurology.  During his years as a VMO and Staff Specialist in Dermatology at Royal North Shore Hospital, Sydney, he also ran specialist clinics in surgical dermatology, hidradenitis suppurativa, and renal transplant cutaneous medicine.

Professor Smith has been a supervisor or auxiliary supervisor for PhD, Masters, Honours and MD research project students. He has over 90 peer reviewed journal publications and over 125 published abstracts.  He has also been involved in multiple pharmaceutical trials from phase II to phase IV. He is a frequent media contributor on topics around skin diseases, skin health and sun protection.

Dr Melinda Gooderham (CAN)

Professor Peter van de Kerkhof

Senior professor of the Radboud University and Chief Medical Officer of the International Psoriasis Council

Associate Professor Peter Foley

Baz Hamo

Proparia CEO Baz Hamo (BSc Pharm, Dipl. Formulation)

Chelle Enriquez 

Dermatology nurse

Prof Jo Lambert, Belgium

Dr Diana Rubel, Australia

Diana is a consultant dermatologist in private practice at Woden Dermatology, Canberra, a visiting medical officer at The Canberra Hospital, and Senior Lecturer at the Australian National University (ANU).

She completed her undergraduate medical degree (1988) and postgraduate Diploma in Paediatrics (1992) at the University of NSW, her Masters of Medicine (specialising in cutaneous immunology) at Sydney University (1995) and completed her Postgraduate Specialist training in Dermatology (Australasian College of Dermatologists’ fellowship) in 1998.

She has over 15 years’ experience at the Skin and Cancer Foundation, Darlinghurst, Sydney, and has been a Staff Specialist at the Sydney Childrens Hospital for 10 years.

Her goal is to excel in patient care and service to her patients, her referring doctors and her staff. She is passionate about consistently delivering high quality care to all patients, and has developed special interests in skin cancer management, paediatric dermatology, acne, psoriasis, cosmetic dermatology and clinical trials.

Dr Kilian Eyerich, Germany/Sweden

Kilian Eyerich is chair and professor for Dermatology and Venereology at the Karolinska Institute in Stockholm, Sweden, as well as Heisenberg professor for Dermato-Immunology at the Technical University Munich, Germany. His scientific interest is the interaction of adaptive immune cells and resident epithelial cells in inflammatory skin diseases. His vision is to revise the disease ontology of inflammatory and autoimmune skin diseases based on a clinically meaningful molecular basis.

Kilian Eyerich is PI in numerous translational research projects and clinical trials in the field. He has published more than 150 scientific articles in peer-reviewed journals such as the New England Journal of Medicine as well as journals of the Nature and Science group. His work received numerous awards such as two European Research Council grants and a Heisenberg professorship.  He serves as board member and advisor of numerous academic and private organisations such as being deputy editor of the Journal of Investigative Dermatology.

A/Prof Chris Baker (Chair)
MBBS, FACD, GAICD

Associate Professor Chris Baker AM is the Director of Dermatology at St. Vincent’s Hospital Melbourne and a Consultant Dermatologist in private practice in Melbourne. A graduate of The University of Melbourne, Chris trained at St. Vincent’s Hospital, Melbourne and St. Thomas’ Hospital, London. He is a fellow of the Australasian College of Dermatologists and the Royal College of Physicians (London).

Chris served as Dean of Education and Chief Examiner for the Australasian College of Dermatologists and is a past president of the College. He is a Clinical Associate Professor at The University of Melbourne. He is also past president and board member of the Skin and Cancer Foundation (now Skin Health Institute), Melbourne. He is co-founder of the Australasian Psoriasis Registry and is the Australian Representative on the Psoriasis Global Atlas project.

A/Prof Andrew Miller
Bsc (Medicine) (Hons), MBBS (Hons), FACD

A/Prof Andrew Miller is the former President of the Australasian College of Dermatologists. He has worked in private practice for over 20 years, including as a Visiting Medical Officer at both Calvary Hospital and Canberra Hospital, where he is head of the dermatology department.

A/Prof Miller is a member of the Australian Medical Association (AMA) ‐ Australian Capital Territory (ACT) Board and formerly on the AMA Federal Council as well as a Director of the Council of Presidents of Medical Colleges. He was President of the ACT Australian Medical Association (AMA) from 2012 to 2014. He teaches at the Australian National University Medical School, Canberra, and supervises vocational trainees of the Australasian College of Dermatologists.

In 2018 A/Prof Miller was made a member of the General Division of the Order of Australia for his contribution to the field of Dermatology and professional organisations. In 2019 he was awarded the Australiasian College of Dermatology Silver medal in recognition of outstanding services to the college and the wider dermatology community. A/Prof Miller continues to dedicate time to multiple task forces and consultancy roles, including but not limited to Sandos, Novartis, Jansen, GMA and the National Prescribing Service.In addition to A/Prof Miller’s private practice in Canberra, he conducts rural outreach clinics in Young and Batemans Bay, NSW on a regular basis.He is a passionate advocate for ensuring all Australians look after their skin health.

Prof Peter Nash
MBBS (Hons), FRACP

Peter Nash is Professor in the School of Medicine at Griffith University, Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast. Prof Nash has Chaired the Professional Affairs Committee, the Therapeutics Committee , the NHMRC musculoskeletal panels as well as serving on the Scientific Advisory Committee and ASMPOC of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the International Steering Committee for GRAPPA. He is on the editorial board of Annals of the Rheumatic Diseases and RMD Open.

Prof. Nash and his group at the Rheumatology Research Unit have been involved in the pivotal registration clinical trials for all modern targeted biologic therapies and osteoporosis therapies. He has published more than 200 peer-reviewed papers and 5 book chapters, and was recently recognised as Australian rheumatology leader for citations in the top 20 rheumatology journals over the last 5 years. Special interests include metabolic bone disease and novel therapeutics.

Dr Kim Papp

Dr Annika Smith

Dr Lynda Spelman (Dermatologist; FACD)

Dr. Lynda Spelman is a graduate of the University of Queensland and Fellow of the Australasian College of Dermatologists, she has worked as a specialist dermatologist in Australia for more than 20 years. Dr Spelman is a founder and the current Chair of the Queensland Skin and Cancer Trust. She is also a founder and co-director of the Queensland Institute of Dermatology, a not-for-profit organisation devoted to training, research and the provision of specialist dermatological services to patients across Queensland.

Dr Spelman has an extensive 25 year history of involvement in clinical research, most recently as the Principal Investigator at Veracity Clinical Research. This research pioneers new and innovative treatments for her patient’s with complex dermatological conditions, such as atopic dermatitis, chronic plaque psoriasis, basal cell carcinoma and other inflammatory skin disorders.

Dr Spelman is the principal investigator on The National Dermatology Radiation Oncology Registry (NDROR) is a human research Registry that collects and collates information from patients referred for radiotherapy for the management of non-melanoma and melanoma skin cancer and difficult to manage inflammatory skin diseases.

Dr Patrick Francke (Radiation Oncologist; MD FACRO)

Dr Francke is a Radiation Oncologist who completed his residency at the University of Kentucky Medical Center, and is now the medical director of Radiation Oncology at GenesisCare, Myrtle Beach, South Carolina, USA.

Dr Francke has published and lectured on many topics relating to radiation therapy applications to cancer. His publications cover several randomized clinical trials investigating strategies to improve the dosimetry and toxicity profiles of novel radiation modalities for the treatment of malignancies.

He has more than 20 years of clinical experience and serves on several committees and panels with professional organizations including the American College of

Radiation Oncology, American Society for Therapeutic Radiology and Oncology, and the American Society for Radiation Oncology (ASTRO).

Professor Stephen Shumack is a general Dermatologist who has over 30 years experience in managing a broad range of dermatological conditions.

He is a Clinical Associate Professor, Department of Dermatology at the University of Sydney, and Senior Staff Specialist at the Royal North Shore Hospital of Sydney. He is also the Chair of the Board of the Skin and Cancer Foundation Australia. He is a past President of the Australasian College of Dermatologists, and he is on the Editorial Board of the Australasian Journal of Dermatology, having previously been the Editor in Chief. He also was Chair of the recent Cancer Council Australia Keratinocyte Cancer Guidelines Revision Committee. He is a current member of the Board of the International League of Dermatological Societies and is the Vice Treasurer of that organization. He is also Vice Chair of the International Foundation for Dermatology.

Professor Shumack also runs a clinical research arm at his private practice in Sydney. This is under the umbrella of Probity Medical Research. He has published and spoken widely on many aspects of dermatological care including psoriasis, eczema and skin cancer diagnosis, management and research.

He has been awarded the Order of Australia Medal in 2011 for his services to Dermatology and the Community, the Silver Medal from the Australasian College of Dermatologists, and the Foundation Medal from the Skin and Cancer Foundation Australia.

Prof. Pablo Fernández-Peñas

Sydney Medical School, The University of Sydney, Sydney, Australia

Professor Pablo Fernández-Peñas is the Head of Dermatology at the Westmead Hospital in Sydney, Australia, as well as the Co-Head of the Discipline of Dermatology at the University of Sydney. He co-leads the Melanoma and Skin Cancer Group, at the Westmead Institute for Medical Research, and is the New South Wales lead for the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis.

Professor Fernández-Peñas specialises in oncodermatology, immunology, quality of life in dermatology and information technologies. He has over 180 publications and has participated in the development of more than 50 clinical trials, many of which were carried out in the Dermatology Clinical Trials and Research Unit, which he founded.

Dr Lynda Spelman

Veracity Clinical Research, Queensland, Australia

Dr Lynda Spelman is one of the founders and the current Chair of the Queensland Skin and Cancer Trust, in Australia, as well as the Founder and Director of the Queensland Institute of Dermatology. She completed her Fellowship at the Australasian College of Dermatologists in 1993, after obtaining a Bachelor of Medicine and Bachelor of Surgery degree from the University of Queensland.

Dr Spelman has more than 25 years of experience in dermatological clinical research. Her cutting-edge research involves the development of new and innovative treatments for dermatological indications including chronic plaque psoriasis, atopic dermatitis, basal cell carcinoma and inflammatory skin disorders. She is also the Principal Investigator of Veracity Clinical Research, a dermatology clinical research company investigating inflammatory skin conditions.

Dr Sandy McBride

Consultant Dermatologist, Royal Free London NHS Foundation Trust, UK

Dr Sandy McBride is a consultant dermatologist at the Royal Free London NHS Foundation Trust. She currently serves as the dermatology lead for the Royal Free psycho-dermatology service and is a member of the British Association of Dermatologists psycho-dermatology working party.

Dr McBride has a special interest in psoriasis and the psychological impact of skin conditions. As well as performing general dermatology, she leads a multi-disciplinary psoriasis service which aims to provide holistic care to people with psoriasis.

Prof EMMA GUTTMAN-YASSKY, MD, PhD

Emma Guttman-Yassky, MD, PhD is the Waldman Professor and System Chair of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City. She is the Director of the Center for Excellence in Eczema and the Occupational Dermatitis Clinic and Director of the Laboratory for Inflammatory Skin Diseases. She earned her MD degree from Sackler School of Medicine at the Tel-Aviv University, and a PhD degree from the Bar-Ilan University, Israel. After obtaining her Israeli Board certification in dermatology at Rambam Medical Centre/Technion, Israel, Dr. Guttman moved to the U.S. to pursue a two-year postdoctoral fellowship at The Rockefeller University in the Laboratory for Investigative Dermatology. Upon completion of her fellowship, she became board-certified by the American Board of dermatology after a second dermatology residency training at the Weill-Cornell Medical College, in NY. Dr. Guttman’s major clinical and research focus areas are atopic dermatitis (AD)/eczema and alopecia areata. Her research made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis (AD)/eczema in adults and children with atopic dermatitis, enriching the understanding of the pathophysiology of this common disorder, opening the door and accelerating testing of novel immune, pathway-specific drugs in this disease. She is now testing (both clinically and mechanistically) multiple targeted therapeutics for atopic dermatitis that target Th2, Th22, and Th17/IL-23 axis. Recently Dr. Guttman also extended her research interest to hair loss disorders such as alopecia areata and scarring hair loss disorders, chronic hand eczema, keloids, ichtyosis, and other skin diseases, in which her findings are also translated to novel therapeutic targets. Dr. Guttman is considered one of the world’s leading experts in inflammatory skin diseases. Her achievements have been repeatedly highlighted by the media including the New York Times, ABC News, CBS News, Daily News, Reuters, Wall Street Journal, NY1, and others.

Dr. Guttman divides her time between a busy clinic, where she sees patients from all over the US and the world, that are coming to seek her advice in treating inflammatory skin diseases, and her growing laboratory that focuses on research on the mechanisms underlying inflammatory skin diseases, leading to novel treatments for these patients. She co-founded the International Eczema Council (IEC), for which she functions as president since early 2018. Dr. Guttman received many national and international awards, including the American Academy of Allergy and Clinical Immunology (AAAAI) Award for Scientific Innovation, American Academy of Dermatology Young Investigator awards, and others. She was elected as a member to the American Society for Clinical Investigation (ASCI), as well as the American Dermatological Society (ADA). Dr. Guttman is often invited as a keynote speaker to international and national meetings, and authored ~240 peer-reviewed publications. Dr. Guttman is also the co-organizer of the Inflammatory Skin Disease Summit, that is considered one of the most successful meetings in dermatology

Dr Annika Smith (Chair)
MBBS (Hons 1), MPHTM, FRACP, FACD

Prof Fernández-Peñas:
MD, PhD, FACD

A/Prof Gillian Marshman
MBBs, FACD

Associate Professor John Su

Dr Katherine Armour

Dermatology Institute of Victoria

Dr Rodrigo Roldán

San Ángel Inn University Hospital

Andrew F. Alexis

Professor of Clinical Dermatology – Weill Cornell Medical College, Cornell University